Audrey Clapéron

Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure

María Elena Fernández-Sánchez, Sandrine Barbier, Joanne Whitehead et al. · Nature · 2015 · 369 citations

Medicine, Cancer Biology, Cell Biology +16

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Donia M. Moujalled, Giovanna Pomilio, Corina Ghiurau et al. · Leukemia · 2018 · 174 citations · Full text

Medicine, Oncology, Pharmacology +17

EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition

Audrey Clapéron, Martine Mergey, Thanh Huong Nguyen Ho-Bouldoires et al. · Journal of Hepatology · 2014 · 129 citations

Medicine, Cell Biology, Oncology +13

Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors

Hamza Chettouh, Lynda Aoudjehane, Dominique Wendum et al. · Cancer Research · 2013 · 125 citations

Life Sciences, Molecular Biology, Oncology +17

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Patrick Casara, James Davidson, Audrey Clapéron et al. · Oncotarget · 2018 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17